Analyst consensus rating
BioLife Solutions Analyst Rating: Hold
BLFS is rated Hold by 7 analysts with a $31.29 target. As of 2026-08-24.
Direct answer
BioLife Solutions's consensus rating is Hold.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.29.
Forecast evidence checked August 24, 2026.
Get free BioLife Solutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $37.10
- Average price target
- $31.29
- High price target
- $33.00
- Low price target
- $31.00
- Low target gap
- -16.4%
- Target upside
- -15.7%
- High target gap
- -11.1%
- Target range width
- 5.4%
- Consensus rating
- Hold
- Analysts
- 7
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioLife Solutions?
BioLife Solutions has a verified Hold consensus. The same dataset has an average price target of $31.29.
How far are BioLife Solutions's low and high targets from the recorded price?
The low target implies -16.4%, while the high target implies -11.1%.
How many analysts are included in BioLife Solutions's consensus?
The verified consensus includes 7 analysts.
How is BioLife Solutions's target upside or downside calculated?
The average target of $31.29 is divided by the recorded price of $37.10, then one is subtracted to produce -15.7%. This does not guarantee a future return.
When was BioLife Solutions's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.